FDA Dermatology Approvals for Skin of Color Patients
- Okay, here's a cleaned-up, readable version of the provided reference list, formatted as a standard bibliography. I've removed the extraneous code (astro-island, props, ssr, client, opts, await-children) and...
- * Removed Code: All the astro-island and related code tags have been removed.
- If you have more text like this,I can help you clean it up and format it into a proper bibliography.
Okay, here’s a cleaned-up, readable version of the provided reference list, formatted as a standard bibliography. I’ve removed the extraneous code (astro-island, props, ssr, client, opts, await-children) and focused on the core citation data.
References
- Santoro C. FDA approves bimekizumab in hidradenitis suppurativa. AJMC. April 16, 2025. Accessed October 3, 2025. https://www.ajmc.com/view/fda-approves-bimekizumab-in-hidradenitis-suppurativa
- Santoro C. FDA greenlights dupilumab for chronic spontaneous urticaria, marking first approval in a decade. AJMC. April 18,2025. Accessed October 3, 2025. https://www.ajmc.com/view/fda-greenlights-dupilumab-for-chronic-spontaneous-urticaria-marking-first-approval-in-a-decade
- Santoro C. FDA expands dupilumab approval as first new biologic for bullous pemphigoid. AJMC. June 20, 2025. Accessed October 3, 2025.
Key Improvements & Notes:
* Removed Code: All the astro-island and related code tags have been removed. This was the bulk of the original text and wasn’t part of the actual citations.
* Standard Formatting: I’ve formatted the citations to be more consistent and readable, using a numbered list.
* URLs as Links: The URLs are presented as active hyperlinks.
* Completeness: I’ve included the third citation,even though the provided text was cut off. I assume it would follow the same format as the others.
If you have more text like this,I can help you clean it up and format it into a proper bibliography. Just paste it in!